Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Lower Extremity Ulcers

To prospectively evaluate the safety and efficacy of an Autologous Platelet-Rich Fibrin Plasma system when applied in conjunction with Standard of Care for management of chronic lower extremity wounds.

Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Tiger Biosciences, LLC.Updated: Oct 7, 2026
Eligibility criteria

Female or Male, plus ≥18 years of age at the time the study Informed Consent is... [+13]

Ulcer is not medically diagnosed as a lower extremity wound. [+25]

Status: Not yet recruiting

Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers

To prospectively evaluate the safety and efficacy of an Autologous Platelet-Rich Fibrin Plasma system when applied in conjunction with Standard of Care for management of chronic Diabetic Foot Ulcers.

Participants needed: 55
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Tiger Biosciences, LLC.Updated: Sep 25, 2026
Eligibility criteria

Female or Male, plus ≥18 years of age at the time the study Informed Consent is... [+17]

Ulcer is not medically diagnosed as DFU pathophysiology. [+28]

Status: Recruiting

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers

The purpose of this study it to evaluate several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus matched standard of care controls in the management of nonhealing pressure ulcers.

Participants needed: 500
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Tiger Biosciences, LLC.Updated: Sep 23, 2026Locations: 1
Eligibility criteria

The potential subject must be at least 18 years of age or older. [+5]

The potential subject is known to have a life expectancy of < 3 months. [+15]

Status: Recruiting

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

Title A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform (Matriarch) Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care versus Standard of Care alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

Participants needed: 340
Trial details
Phase: Phase 4Age: 21+Biological sex: AllType: InterventionalSponsor: Tiger Biosciences, LLC.Updated: Sep 22, 2026Locations: 1
Eligibility criteria

Subjects The potential subject must be at least 21 years of age or older. [+10]

The potential subject must consent to using the prescribed offloading method for... [+50]